TW
CVS icon

TrinityPoint Wealth’s CVS Health CVS Stock Holding History

TrinityPoint Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$307K Sell
6,833
-59,103
-90% -$3.32M 0.04% 267
2024
Q3 		$4.15M Sell
65,936
-3,468
-5% -$202K 0.6% 40
2024
Q2 		$4.1M Buy
69,404
+17,126
+33% +$1.07M 0.64% 34
2024
Q1 		$4.17M Sell
52,278
-57,417
-52% -$4.39M 0.69% 31
2023
Q4 		$8.66M Sell
109,695
-581
-0.5% -$41.4K 1.57% 10
2023
Q3 		$7.7M Buy
110,276
+701
+0.6% +$49.7K 1.53% 9
2023
Q2 		$7.57M Buy
109,575
+5,400
+5% +$384K 1.48% 11
2023
Q1 		$7.74M Buy
104,175
+18,207
+21% +$1.53M 1.66% 11
2022
Q4 		$8.01M Buy
85,968
+327
+0.4% +$31.6K 1.82% 9
2022
Q3 		$8.17M Buy
85,641
+1,106
+1% +$109K 1.87% 8
2022
Q2 		$7.83M Sell
84,535
-965
-1% -$94.2K 1.73% 10
2022
Q1 		$8.65M Sell
85,500
-33,857
-28% -$3.56M 1.57% 11
2021
Q4 		$12.3M Sell
119,357
-490
-0.4% -$45.3K 2.19% 7
2021
Q3 		$10.2M Sell
119,847
-450
-0.4% -$37.7K 1.95% 8
2021
Q2 		$10M Buy
120,297
+544
+0.5% +$44.5K 2.05% 7
2021
Q1 		$9.01M Buy
119,753
+84
+0.1% +$6.12K 2.1% 7
2020
Q4 		$8.88M Buy
119,669
+22,157
+23% +$1.44M 2.14% 7
2020
Q3 		$5.7M Buy
97,512
+1,778
+2% +$111K 1.58% 11
2020
Q2 		$6.22M Sell
95,734
-1,559
-2% -$98.2K 1.97% 7
2020
Q1 		$5.77M Buy
97,293
+25,755
+36% +$1.72M 2.29% 7
2019
Q4 		$5.32M Sell
71,538
-397
-0.6% -$27.9K 1.79% 10
2019
Q3 		$4.89M Buy
71,935
+20,688
+40% +$1.23M 1.7% 10
2019
Q2 		$2.87M Buy
+51,247
New +$2.76M 1.38% 14

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TrinityPoint Wealth's CVS Position: Q4 2024 in Review

TrinityPoint Wealth reduced its CVS Health (CVS) stake by 90% in Q4 2024, selling an estimated $3.32M and leaving 6,833 shares worth $307K. The position accounts for 0.04% of the portfolio, ranked #267.

TrinityPoint Wealth first reported a position in CVS in Q2 2019 and has held it in 23 quarters since. The position peaked at $12.3M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • TrinityPoint Wealth held 6,833 shares of CVS Health worth $307K as of Q4 2024.
  • TrinityPoint Wealth sold 59,103 CVS Health shares in Q4 2024, an estimated $3.32M.
  • CVS Health made up 0.04% of TrinityPoint Wealth's portfolio in Q4 2024, its #267 holding.
  • TrinityPoint Wealth first reported a position in CVS Health in Q2 2019 and has held it in 23 quarters since.
  • TrinityPoint Wealth's CVS Health position peaked at $12.3M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.